Novel composition for treatment of essential thrombocythemia

Details for Australian Patent Application No. 2011231557 (hide)

Owner AOP Orphan Pharmaceuticals AG

Inventors Widmann, Rudolf; Strieder, Georg

Agent TJIP

Pub. Number AU-A-2011231557

PCT Pub. Number WO2011/117391

Priority 10157772.4 25.03.10 EP

Filing date 25 March 2011

Wipo publication date 29 September 2011

International Classifications

A61K 9/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/517 - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Event Publications

4 October 2012 PCT application entered the National Phase

  PCT publication WO2011/117391 Priority application(s): WO2011/117391

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011231558-Substitute therapy for glucocorticoids

2011231546-Preparation of hydrated polymorphs of 4-amino-5-fluoro-3-[6-(4methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one lactic acid salt